BioSpace News Archive

Technologies for screening donated blood for infectious such as HIV1, HIV2, HBV, and HCV play a crucial role in deciding the safety of transfusions.

Transparency Market Research has published a new report titled, “Anal Fistula Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026”.

The European Patent Office has informed Diamyd Medical that the Company’s patent application regarding prevention and treatment of autoimmune diabetes in individuals carrying the HLA DR3-DQ2 gene will be granted.

Brings leadership experience from Agios Pharmaceuticals and Novartis Vaccines with strategy and operations expertise across many stages of product development and company growth

Antibe Therapeutics Inc. today announced its participation in the Canaccord Genuity 41st Annual Growth Conference being held virtually on August 10 - 12.

KalVista Pharmaceuticals, Inc., announced that the compensation committee of KalVista’s board of directors granted four newly-hired employees inducement options to purchase an aggregate of 20,000 shares of KalVista common stock on August 3, 2021 as inducements material to each employee entering into employment with KalVista.

Company to host conference call and webcast at 8:30 a.m. EDT

Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and marketer of innovative, plant-based health and wellness products, today announced that it will release its financial and business results for the second quarter and first half 2021 after market close on August 16, 2021.